ARTICLE I BOARD OF DIRECTORS ------------------Voting Agreement • December 24th, 2009 • Maverick Capital LTD • Retail-catalog & mail-order houses • Delaware
AGREEMENT ---------Note Purchase Agreement • July 25th, 2008 • Maverick Capital LTD • Retail-catalog & mail-order houses • New York
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT -------------------------------------------------- THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this "Agreement") is entered into as of September 7, 2011, by and among Bluefly, Inc., a...Registration Rights Agreement • September 13th, 2011 • Maverick Capital LTD • Retail-catalog & mail-order houses • New York
EXECUTION COPY REGISTRATION RIGHTS AGREEMENT ----------------------------- THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is entered into as of December 21, 2009, by and among Bluefly, Inc., a Delaware corporation (the "Company"), Quantum...Registration Rights Agreement • December 24th, 2009 • Maverick Capital LTD • Retail-catalog & mail-order houses • New York
STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 28th, 2013 • Maverick Capital LTD • Retail-catalog & mail-order houses • Delaware
Joint Filing AgreementJoint Filing Agreement • February 14th, 2006 • Maverick Capital LTD • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, $0.001 par value of Metabasis Therapeutics, Inc., dated as of February 14, 2005, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 16th, 2016 • Maverick Capital LTD • Radio & tv broadcasting & communications equipment
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, par value $0.01 of CommScope Holding Company, Inc., dated as of February 16, 2016, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2019 • Maverick Capital LTD • Services-offices & clinics of doctors of medicine
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Common Stock, $0.01 par value of Envision Healthcare Corporation, dated as of February 14, 2019, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Maverick Capital LTD • Services-general medical & surgical hospitals, nec
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class B Common Stock of Universal Health Services, Inc., dated as of February 14, 2017, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 16th, 2016 • Maverick Capital LTD • Surety insurance
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Common Stock, par value $0.001 per share of Radian Group Inc., dated as of February 17, 2015, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Maverick Capital LTD • Radio & tv broadcasting & communications equipment
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, par value $0.01 of CommScope Holding Company, Inc., dated as of February 16, 2016, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 15th, 2017 • Maverick Capital LTD • Retail-eating places
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Common Stock, par value $0.01 per share of Aramark, dated as of February 14, 2017, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Panacea Acquisition Corp. II dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Maverick Capital LTD • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, $0.01 par value of Impax Laboratories, Inc. dated as of February 12, 2018, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Curis, Inc. dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Global Technology Acquisition Corp. I dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
THIS INSTRUMENT IS SUBJECT TO THE TERMS OF A SUBORDINATION AND INTERCREDITOR AGREEMENT, DATED MARCH 26, 2008, BETWEEN WELLS FARGO RETAIL FINANCE, LLC, A DELAWARE LIMITED LIABILITY COMPANY, QUANTUM INDUSTRIAL PARTNERS LDC, A CAYMAN ISLANDS LIMITED...Subordination and Intercreditor Agreement • July 25th, 2008 • Maverick Capital LTD • Retail-catalog & mail-order houses • New York
THIS INSTRUMENT IS SUBJECT TO THE TERMS OF A SUBORDINATION AND INTERCREDITOR AGREEMENT, DATED MARCH 26, 2008, BETWEEN WELLS FARGO RETAIL FINANCE, LLC, A DELAWARE LIMITED LIABILITY COMPANY, QUANTUM INDUSTRIAL PARTNERS LDC, A CAYMAN ISLANDS LIMITED...Subordination and Intercreditor Agreement • July 25th, 2008 • Maverick Capital LTD • Retail-catalog & mail-order houses • New York
Joint Filing AgreementJoint Filing Agreement • February 16th, 2016 • Maverick Capital LTD • Laboratory analytical instruments
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Common Stock, $0.0001 par value of Pacific Biosciences of California, Inc., dated as of February 17, 2015, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • April 10th, 2014 • Maverick Capital LTD • Services-computer processing & data preparation
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class B Common Stock, $0.0001 par value per share of Castlight Health, Inc., dated as of April 10, 2014, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Dragoneer Growth Opportunities Corp. III dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Orion Acquisition Corp. dated as of February 14, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares, $0.0001 par value per share of Ajax I, dated as of February 16, 2021, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Maverick Capital LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Invivyd, Inc., dated as of February 14, 2024, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Maverick Capital LTD • Services-computer processing & data preparation
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Common Stock of Castlight Health, Inc. dated as of February 14, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Wave Life Sciences Ltd., dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Maverick Capital LTD • Retail-computer & computer software stores
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Common Stock, $.001 par value of GameStop Corp., dated as of February 14, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • May 10th, 2017 • Maverick Capital LTD • Services-computer processing & data preparation
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Class B Common Stock, $0.0001 par value per share of Castlight Health, Inc., dated as of February 17, 2015, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Dragoneer Growth Opportunities Corp. III dated as of February 14, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G/A with respect to the Common Stock of Atara Biotherapeutics, Inc. dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Maverick Capital LTD • Blank checks
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Ordinary Shares, $0.0001 par value per share of Population Health Investment Co., Inc., dated as of February 16, 2021, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • May 23rd, 2023 • Maverick Capital LTD • Blank checks
The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Maverick Capital LTD • Retail-catalog & mail-order houses
The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Common Stock of Coupang, Inc. dated as of February 14, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Maverick Capital LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Curis, Inc. dated as of February 14, 2024, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Purchaser Warrant Amount --------- -------------- QIP 316,659 SFMDI 10,364 Maverick USA 37,725 Maverick L.D.C. 85,577 Maverick II 74,677Maverick Capital LTD • March 28th, 2008 • Retail-catalog & mail-order houses • New York
